Hypereosinophilic syndrome and mepolizumab
- PMID: 18589879
- PMCID: PMC2596663
Hypereosinophilic syndrome and mepolizumab
Comment on
-
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.N Engl J Med. 2008 Mar 20;358(12):1215-28. doi: 10.1056/NEJMoa070812. Epub 2008 Mar 16. N Engl J Med. 2008. PMID: 18344568 Clinical Trial.
References
-
- Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis. 2006;42:363–367. - PubMed
-
- Posey DL, Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloides among African refugees. Clin Infect Dis. 2007;45:1210–1215. - PubMed
-
- Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66:749–752. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources